Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Miller Mary sold 513 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Oct 22, 2026 · Filed Oct 26, 2026
On Oct 22, 2026, Miller Mary (Chief Legal Officer) sold 513 Acrivon Therapeutics, Inc. shares at US$1.84 for US$944, leaving 81,202 shares. Filed Oct 26, 2026 (Form 4).
- Sold
- 513 shares
- Price
- US$1.84
- Value
- US$944
- Holding after
- 81,202 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Common Stock | Sale | 513 | US$1.84 | 81,202 | Direct |
Source
Download original · View original at SEC
Related
- Acrivon Therapeutics, Inc.
- Miller Mary
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Miller Mary · Nov 19, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Miller Mary · Aug 20, 2026
- Form 4 · Miller Mary · Jul 23, 2026
- Form 4 · Miller Mary · May 20, 2026
- Form 4 · Devroe Eric · Nov 19, 2026
- Form 4 · Blume-Jensen Peter · Nov 19, 2026
- Form 4 · Peterson Katharine · Nov 19, 2026
- Form 4 · Gamelin Erick · Nov 19, 2026
- Form 4 · Levin Michaela · Sep 2, 2026